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AbstrACt
Objectives To investigate the association between 
the mode of birth and adverse neonatal outcomes of 
macrosomic (birth weight ≥4000 g) and non-macrosomic 
(birth weight <4000 g) live-born term singletons in vertex 
presentation (TSV) born to mothers with diabetes (pre-
existing and gestational diabetes mellitus (GDM)).
Design A population-based retrospective cohort study.
setting New South Wales, Australia.
Patients All live-born TSV born to mothers with diabetes 
from 2002 to 2012.
Intervention Comparison of neonatal outcomes by mode 
of birth (prelabour caesarean section (CS) and planned 
vaginal birth resulted in intrapartum CS, non-instrumental 
or instrumental vaginal birth).
Main outcome measures Five-minute Apgar score <7, 
admission to neonatal intensive care unit (NICU) or special 
care nursery (SCN) and the need for resuscitation.
results Among the 48 882 TSV born to mothers with 
diabetes, prelabour CS was associated with a significant 
increase in the rate of admission to NICU/SCN compared 
with planned vaginal birth. For TSV born to mothers with 
pre-existing diabetes, compared with non-instrumental 
vaginal birth, instrumental vaginal birth was associated 
with increased odds of the need for resuscitation in 
macrosomic (adjusted ORs (AOR) 2.6; 95% CI (1.2 to 
7.5)) and non-macrosomic TSV (AOR 3.3; 95% CI (2.2 to 
5.0)). For TSV born to mothers with GDM, intrapartum 
CS was associated with increased odds of the need for 
resuscitation compared with non-instrumental vaginal birth 
in non-macrosomic TSV (AOR 2.3; 95% CI (2.1 to 2.7)). 
Instrumental vaginal birth was associated with increased 
likelihood of requiring resuscitation compared with non-
instrumental vaginal birth for both macrosomic (AOR 2.3; 
95% CI (1.7 to 3.1)) and non-macrosomic (AOR 2.5; 95% CI 
(2.2 to 2.9)) TSV.
Conclusion Pregnant women with diabetes, particularly 
those with suspected fetal macrosomia, need to be aware 
of the increased likelihood of adverse neonatal outcomes 
following instrumental vaginal birth and intrapartum CS 
when planning mode of birth.
IntrODuCtIOn
Diabetes during pregnancy is associated 
with increased incidence of adverse baby 
outcomes.1 Babies born to mothers with 
diabetes during pregnancy are at higher 
risk of perinatal mortality and morbidity 
including preterm birth, congenital abnor-
mality, neonatal hypoglycaemia and macro-
somia.2 
There is little consistency internationally 
regarding recommendations on the mode of 
birth for women with diabetes during preg-
nancy. Variations are seen in both national 
and professional society guidelines and 
recommendations.2 The American College 
of Obstetricians and Gynecologists guide-
lines recommend caesarean section (CS) for 
women with diabetes during pregnancy with 
What is already known on this topic?
 ► Diabetes during pregnancy is associated with 
adverse neonatal and long-term baby outcomes.
 ► There is no agreement in the national and 
international guidelines about the best mode of 
birth for women with diabetes during pregnancy.
What this study hopes to add?
 ► Diabetic women gave birth to macrosomic term 
singletons in vertex presentation are likely to 
give birth by intrapartum caesarean section (CS) 
and those who gave birth to non-macrosomic by 
instrumental birth.
 ► Intrapartum CS and instrumental vaginal birth are 
associated with increased likelihood of adverse 
neonatal outcomes.
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an estimated birth weight >4500 g.3 4 The National Insti-
tute for Health and Care Excellence (NICE) guideline 
in the UK recommends induction of labour or elective 
CS if indicated, between 37+0 and 38+6 weeks of gestation 
for women with pre-existing diabetes.5 For women with 
gestational diabetes mellitus (GDM), the NICE guide-
line recommends elective birth no later than 40+6 weeks 
of gestation.5 The Australasian Diabetes in Pregnancy 
Society (ADIPS) guidelines advise that for women with 
pre-existing diabetes, elective CS should be considered if 
estimated birth weight exceeds 4250–4500 g.6 For women 
with uncomplicated GDM, ADIPS guideline does not 
recommend birth before term unless there is an obstetric 
indication.7
The rate of CS is high among women with diabetes 
during pregnancy in Australia.8 The leading reasons 
for a planned CS (prelabour CS) are for the prevention 
of stillbirth and the reduction of birth complications 
associated with macrosomia.2 9 Currently, there are no 
population-based studies in Australia that have evaluated 
the neonatal outcomes of babies born to mothers with 
diabetes according to the mode of birth.
Our study aimed to compare adverse neonatal 
outcomes for live-born term singletons in vertex presen-
tation (TSV) born to mothers with diabetes during 
pregnancy (pre-existing diabetes and GDM) by mode of 




A population-based retrospective cohort study was 
conducted using the New South Wales (NSW) Perinatal 
Data Collection (PDC).10 The PDC is a population-based 
surveillance system. It includes all births occurring in 
NSW public and private hospitals as well as home births. 
Women giving birth to live births and stillbirths of at least 
20 weeks or at least 400 g birth weight are included in the 
database. Around 32% of the Australian population lives 
in NSW, and more than 95 000 women give birth in this 
state annually.11 12
The NSW PDC is based on electronic forms that are 
completed at birth by the attendants. Information on 
maternal demographics, maternal health, pregnancy, 
obstetric complications, labour and perinatal outcomes 
is included in the form. The forms are submitted to NSW 
Ministry of Health where the information is validated 
and compiled into the statewide PDC.10
study population
There were 48 983 TSV born during the study period of 
which 101 are stillbirths (18 (0.4%) born to mothers with 
pre-existing diabetes and 83 (0.2%) born to mothers 
with GDM). Due to our inability to identify times of 
stillbirth (antepartum or intrapartum), these stillbirths 
were excluded from the study. The study includes all 
live-born TSV (n=48 882) born in NSW to mothers with 
diabetes during pregnancy between 1 January 2002 and 
31 December 2012. Of these, 4501 (9.2%) were born to 
mothers with pre-existing diabetes and 44 381 (90.8%) 
were born to mothers with GDM.
Of our study population, 276 (0.4%) TSV were 
excluded from the multivariate logistic regression due 
to admission to neonatal intensive care unit (NICU) or 
special care nursery (SCN) with one or more diagnosed 
birth defects, and 71 (0.1%) were excluded because of 
missing data (mode of birth, birth weight and admission 
to NICU or SCN due to birth defect). A total of 4458 live-
born TSV born to mothers with pre-existing diabetes and 
44 148 born to mothers with GDM were included in the 
multivariate logistic regression.
study factors and outcome measurements
Pre-existing diabetes includes type I and type II. GDM is 
defined as glucose intolerance that is diagnosed for the 
first time during pregnancy which may include hypergly-
caemia induced by pregnancy or previously undiagnosed 
existing abnormalities of glucose tolerance.13
Modes of birth include non-instrumental and instru-
mental vaginal births, prelabour CS (often known as an 
elective CS) and intrapartum CS. Planned vaginal births 
are births that were primarily intended to be non-in-
strumental vaginal births, although they might end with 
intrapartum CS, instrumental vaginal birth or non-instru-
mental vaginal birth.
The definition for macrosomia adopted by the Interna-
tional Association of Diabetes in Pregnancy Study Group 
of birth weight ≥4000 g was used.14 ‘Large for gestational 
age’ was defined as a birth weight greater than the 90th 
percentile for gestational age and ‘small for gestational 
age’ is birth weight less than the 10th percentile.14
Adverse neonatal outcomes were 5 min Apgar score <7, 
neonate admission to NICU or SCN, and the need for 
resuscitation which included resuscitation by intermit-
tent positive pressure respiration by bag and mask, intu-
bation, and intermittent positive pressure respiration, 
external cardiac massage and ventilation.
statistical analysis
Maternal characteristics and baby outcomes were 
compared by mode of birth using Χ2 test. Trend analysis 
was used to compare the rate of prelabour CS by year 
using Mantel-Haenszel test for trend analysis.
Multivariate logistic regression was used to investi-
gate the likelihood of adverse neonatal outcomes by 
mode of birth. Two analyses were conducted; the first 
compared TSV born by prelabour CS with TSV born by 
all other modes of birth combined as planned vaginal 
births. This first analysis was performed to inform 
the decision of performing prelabour CS or proceed 
to planned vaginal birth. The second compared TSV 
born by non-instrumental vaginal birth, TSV who were 
planned as vaginal births but for whom resorting to 
instrumental birth and intrapartum CS, and TSV born 
by prelabour CS. The second analysis was performed to 
3Zeki R, et al. BMJ Paediatrics Open 2018;2:e000224. doi:10.1136/bmjpo-2017-000224
Open Access
help inform the decision in the situation where vaginal 
birth is planned.
Adjusted OR (AOR) and 95% CI were presented. 
The adjustment was made for maternal age, maternal 
country of birth (Australian-born mothers, overseas-born 
mothers), parity (no previous pregnancies; one, two, 
three or more previous pregnancies), smoking during 
pregnancy (smoked, did not smoke), essential and 









n=1286 (%) n=1969 (%) n=397 (%) n=849 (%)
Age (years)
  <20 11 0.9 33 1.7 10 2.5 9 1.1
  20–24 85 6.6 185 9.4 57 14.4 91 10.7
  25–29 246 19.1 436 22.1 89 22.4 209 24.6
  30–34 434 33.7 675 34.3 143 36.0 271 31.9
  35–39 391 30.4 502 25.5 71 17.9 207 24.4
  ≥40 119 9.3 138 7.0 27 6.8 62 7.3
Parity
  Primiparae 304 23.6 487 24.7 280 70.5 553 65.1
  Multiparae 980 76.2 1480 75.2 115 29.0 296 34.9
  Not stated 2 0.2 2 0.1 2 0.5 0 0.0
Number of previous caesarean section*
  None 136 13.9 1380 93.2 96 83.5 149 50.3
  One 602 61.4 67 4.5 19 16.5 115 38.9
  Two or more 239 24.4 4 0.3 0 0.0 31 10.5
  Not stated 3 0.3 29 2.0 0 0.0 1 0.3
Country of birth
  Australian born 862 67.0 1204 61.1 256 64.5 586 69.0
  Overseas born 420 32.7 760 38.6 140 35.3 262 30.9
  Not stated 4 0.3 5 0.3 1 0.3 1 0.1
Smoking during pregnancy
  Smoked 142 11.0 288 14.6 43 10.8 84 9.9
  Did not smoke 1140 88.6 1677 85.2 352 88.7 764 90.0
  Not stated 4 0.3 4 0.2 2 0.5 1 0.1
Birth weight (g)
  Less than 4000 888 69.1 1659 84.3 342 86.1 635 74.8
  4000 and over 397 30.9 310 15.7 54 13.6 214 25.2
  Not stated 1 0.1 0 0.0 1 0.3 0 0.0
Small for gestational age 62 4.8 151 7.7 23 5.8 50 5.9
Large for gestational age 508 39.5 332 16.9 70 17.6 291 34.3
Sex
  Male 682 53.0 962 48.9 208 52.4 446 52.5
  Female 604 47.0 1007 51.1 189 47.6 403 47.5
Gestational age (weeks)
  37 290 22.6 241 12.2 59 14.9 177 20.8
  38 610 47.4 599 30.4 153 38.5 328 38.6
  39 321 25.0 605 30.7 103 25.9 202 23.8
  40 54 4.2 369 18.7 59 14.9 117 13.8
  Greater than 40 11 0.9 155 7.9 23 5.8 25 2.9
*For multipara mothers only.
TSV, term singletons in vertex presentation. 
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n=7958 (%) n=24 946 (%) n=5017 (%) n=6447 (%) 
Age (years)
  <20 22 0.3 300 1.2 49 1.0 73 1.1
  20–24 276 3.5 1882 7.5 374 7.5 518 8.0
  25–29 1227 15.4 6067 24.3 1274 25.4 1539 23.9
  30–34 2690 33.8 8849 35.5 1899 37.9 2219 34.4
  35–39 2734 34.4 6161 24.7 1142 22.8 1570 24.4
  ≥40 1008 12.7 1684 6.8 279 5.6 527 8.2
  Not stated 1 0.0 3 0.0 0 0.0 1 0.0
Parity
  Primiparae 1644 20.7 7747 31.1 3877 77.3 4329 67.1
  Multiparae 6309 79.3 17 191 68.9 1138 22.7 2114 32.8
  Not stated 5 0.1 8 0.0 2 0.0 4 0.1
Number of previous  
caesarean section*
  None 939 14.9 16 086 93.6 922 81.0 978 46.3
  One 3820 60.5 844 4.9 195 17.1 965 45.6
  Two or more 1534 24.3 21 0.1 5 0.4 157 7.4
  Not stated 16 0.3 240 1.4 16 1.4 14 0.7
Country of birth
  Australian born 4353 54.7 12 323 49.4 2172 43.3 3131 48.6
  Overseas born 3587 45.1 12 546 50.3 2824 56.3 3291 51.0
  Not stated 18 0.2 77 0.3 21 0.4 25 0.4
Smoking during pregnancy
  Smoked 607 7.6 2549 10.2 299 6.0 554 8.6
  Did not smoke 7315 91.9 22 308 89.4 4695 93.6 5872 91.1
  Not stated 36 0.5 89 0.4 23 0.5 1 0.0
Birth weight (g)
  Less than 4000 6628 83.3 22 400 89.8 4588 91.4 5494 85.2
  4000 and over 1327 16.7 2544 10.2 428 8.5 953 14.8
  Not stated 3 0.0 2 0.0 1 0.0 0 0.0
Small for gestational age 496 6.2 2590 10.4 667 13.3 651 10.1
Large for gestational age 1652 20.8 2502 10.0 402 8.0 930 14.4
Sex
  Male 4194 52.7 12 471 50.0 2709 54.0 3665 56.8
  Female 3762 47.3 12 470 50.0 2305 45.9 2782 43.2
  Not stated 2 0.0 5 0.0 3 0.1 0 0.0
Gestational age (weeks)
  37 921 11.6 2133 8.6 379 7.6 572 8.9
  38 3271 41.1 6337 25.4 1138 22.7 1639 25.4
  39 3000 37.7 8503 34.1 1695 33.8 2044 31.7
  40 597 7.5 6118 24.5 1367 27.2 1580 24.5
  Greater than 40 169 2.1 1855 7.4 438 8.7 612 9.5
*For multipara mothers only.
TSV, term singletons in vertex presentation. 
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pregnancy-induced hypertension, and hospital sector 
(public, private). The analysis was performed using Statis-
tical Package for Social Science (SPSS) software V.22.0 
(IBM). P value <0.05 or CI not including 1 was consid-
ered statistically significant.
results
Maternal characteristics and baby outcomes are presented 
in tables 1 and 2. Among mothers who went into labour, 
38.8% with pre-existing diabetes and 31.5% with GDM 
gave birth by instrumental vaginal birth or intrapartum 
CS. The highest proportion of mothers aged <25 years 
were among mothers with pre-existing diabetes who gave 
birth by instrumental vaginal birth (16.9%, P<0.001) 
(table 1). The proportion of primipara mothers were 
higher among those who had instrumental vaginal birth 
(70.5% and 77.3% among mothers with pre-existing 
diabetes and mothers with GDM, respectively) (tables 1 
and 2). There were 17 neonatal deaths of which 2 (0.4 
per 1000 live-born TSV) were born to women with pre-ex-
isting diabetes and 15 (0.3 per 1000 live-born TSV) were 
born to women with GDM.
Figure 1 shows an increasing trend in prelabour CS for 
both macrosomic and non-macrosomic TSV. The largest 
increase was seen among macrosomic TSV (P=0.048), 
followed by non-macrosomic TSV born to mothers with 
pre-existing diabetes (P=0.032).
Among mothers with pre-existing diabetes in the 
planned vaginal birth group, the highest rate of instru-
mental vaginal birth was among those who gave birth 
to non-macrosomic TSV who had induction of labour 
(13.2%) (online supplementary figure 1). Mothers 
with GDM who had induction of labour and gave birth 
to non-macrosomic TSV had the highest rate of instru-
mental vaginal birth (15.2%) (online supplementary 
figure 2).
There were no significant changes in the rate of 
admission to NICU/SCN for TSV born to mothers with 
pre-existing diabetes and for macrosomic TSV born 
to mothers with GDM from 2002 to 2012. There was a 
significant increase in the rate of high-level resuscitation 
for non-macrosomic TSV born to mothers with GDM 
between 2002 and 2012.
Prelabour Cs compared with planned vaginal birth
For TSV born to mothers with pre-existing diabetes by 
prelabour CS, there was a significant increase in the odds 
of admission to NICU/SCN compared with TSV born 
by planned vaginal birth (AOR 2.3, 95% CI (1.7 to 3.2) 
for macrosomic TSV; AOR 1.6, 95% CI (1.4 to 1.9) for 
non-macrosomic TSV) (table 3).
non-instrumental vaginal birth compared with other modes 
of birth
TSV born to mothers with pre-existing diabetes
For non-macrosomic TSV, prelabour CS, instrumental 
vaginal birth and intrapartum CS were associated with 
increased odds of admission to NICU/SCN compared 
with non-instrumental vaginal birth (AOR 2.1, 95% CI 
(1.8 to 2.5) for prelabour CS; AOR 1.8, 95% CI (1.4 to 
2.3) for instrumental vaginal birth; AOR 2.4, 95% CI (2.0 
to 3.0) for intrapartum CS). Both instrumental vaginal 
birth and intrapartum CS were associated with a signif-
icant increase in the odds of requiring resuscitation 
compared with non-instrumental vaginal birth (AOR 3.3, 
95% CI (2.2 to 5.0) for instrumental vaginal birth; AOR 
2.3, 95% CI (1.6 to 3.4) for intrapartum CS) (table 4).
For macrosomic TSV, instrumental vaginal birth was 
associated with a significant increase in the odds of 
requiring resuscitation (AOR 2.6, 95% CI (1.2 to 5.7)) 
and admission to NICU/SCN (AOR 2.1, 95% CI (1.1 
to 3.9)) compared with non-instrumental vaginal birth 
(table 4).
TSV born to mothers with GDM
Among non-macrosomic TSV, compared with non-instru-
mental vaginal birth, all other modes of birth were asso-
ciated with increased odds of admission to NICU/SCN 
(AOR 1.5, 95% CI (1.4 to 1.6) for instrumental vaginal 
birth; AOR 1.9, 95% CI (1.7 to 2.0) for intrapartum CS; 
AOR 1.6, 95% CI (1.5 to 1.7) for prelabour CS) and need 
for resuscitation (AOR 2.5, 95% CI (2.2 to 2.9) for instru-
mental vaginal birth; AOR 2.3, 95% CI (2.1 to 2.7) for 
intrapartum CS; AOR 1.5, 95% CI (1.3 to 1.7) for prela-
bour CS) (table 4).
Among macrosomic TSV born to GDM mothers, 
compared with non-instrumental vaginal birth, the 
rate of requiring resuscitation was higher after instru-
mental vaginal birth (AOR 2.3, 95% CI (1.7 to 3.1)) 
and lower after prelabour CS (AOR 0.7, 95% CI (0.6 to 
0.9)) (table 4).
DIsCussIOn
To our knowledge, this Australian study is the largest 
population-based investigation of neonatal outcomes 
related to mode of birth in live-born TSV born to mothers 
with diabetes during pregnancy. The study results showed 
that, among TSV born to mothers with diabetes during 
Figure 1 Rates of prelabour caesarean 
section. GDM, gestational diabetes mellitus. 
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pregnancy, prelabour CS was associated with a signif-
icant increase in the rate of admission to NICU/SCN 
compared with planned vaginal birth. Both instrumental 
vaginal birth and intrapartum CS were associated with 
increased odds of requiring resuscitation compared with 
non-instrumental vaginal birth.
The use of a large validated population-based data set 
with high accuracy15 generates a high level of evidence 
that cannot be achieved in hospital settings. Our study 
provides population-level evidence on the association 
between mode of birth and neonatal outcomes of TSV 
born to mothers with diabetes during pregnancy in NSW. 
Our study also provides information about clinical prac-
tice for mothers with diabetes during pregnancy. The 
validation study by Ampt et al on the NSW PDC shows that 
the PDC had high sensitivity (≥94.7%) and high positive 
predictive value (≥96.1%) in reporting dichotomised 
outcome variables such as 5 min Apgar score <7 and 
neonatal resuscitation.16
The limitation of the study is the lack of information 
on reasons for NICU/SCN admissions as macrosomic 
TSV are routinely admitted to NICU/SCN for expected 
hypoglycaemia without clinical necessity which increases 
the rate of admission to NICU/SCN. Some services do 
have a routine policy of admitting babies born to mothers 
with diabetes to an NICU/SCN, hence the numbers 
could be higher. Another limitation is the lack of infor-
mation on maternal body mass index and on umbilical 
artery pH and lactate levels. To remove the confounding 
related to birth defects, we excluded TSV admitted to 
NICU/SCN because of birth defects from our multivari-
able logistic regression. However, we are unable to adjust 
for maternal body mass index, an independent risk factor 
for adverse pregnancy outcomes such as low Apgar score 
and a higher rate of admission to NICU.17 We used strati-
fication by estimated fetal macrosomia using birth weight 
to limit the impact of maternal body mass index on the 
mode of birth and neonatal outcomes. We are also unable 
to adjust for shoulder dystocia as it was not captured in 
NSW PDC. We also lack information on second-stage CS 
which did not allow us to compare between intrapartum 
CS and instrumental vaginal birth.
There was no significant difference in the odds of 5 min 
Apgar score <7 between TSV born after prelabour CS and 
those born after planned vaginal birth for mothers who 
had pre-existing diabetes or GDM. Stuart et al found a 
Table 3 Adjusted ORs for adverse neonatal outcomes of TSV born to women with diabetes during pregnancy after prelabour 
CS and planned vaginal birth, 2002–2012
Planned vaginal birth† Prelabour caesarean section
n (%) n (%) AOR‡ (95% CI)
Pre-existing diabetes
Birth weight less than 4000 g 2613 880
  5 min Apgar score <7 37 1.4 10 1.1 0.8 (0.4 to 1.6)
  Admitted to NICU/SCN 1180 45.2 495 56.3 1.6* (1.4 to 1.9)
  Need for resuscitation§ 183 7.0 51 5.8 0.9 (0.6 to 1.2)
Birth weight 4000 g and over 574 391
  5 min Apgar score <7 16 2.8 1 0.3 0.1* (0.0 to 0.9)
  Admitted to NICU/SCN 329 57.3 285 72.9 2.3* (1.7 to 3.2)
  Need for resuscitation§ 76 13.2 32 8.2 0.7 (0.4 to 1.1)
Gestational diabetes
Birth weight less than 4000 g 32 330 6590
  5 min Apgar score <7 362 1.1 62 0.9 1.0 (0.7 to 1.3)
  Admitted to NICU/SCN 8613 26.6 2107 32.0 1.4* (1.3 to 1.4)
  Need for resuscitation§ 1752 5.4 326 4.9 1.1 (0.9 to 1.2)
Birth weight 4000 g and over 3911 1317
  5 min Apgar score <7 76 1.9 22 1.7 1.0 (0.6 to 1.6)
  Admitted to NICU/SCN 1288 32.9 610 46.3 1.9* (1.7 to 2.2)
  Need for resuscitation§ 423 10.8 99 7.5 0.7* (0.5 to 0.9)
*P<0.05.
†Reference group.
‡ORs were adjusted for maternal age, maternal country of birth, the number of previous pregnancies, smoking during pregnancy, essential 
and pregnancy-induced hypertension and hospital sector.
§Need for resuscitation includes intermittent positive pressure respiration by bag and mask, intubation and intermittent positive pressure 
respiration as well as external cardiac massage and ventilation.
AOR, adjusted OR; CS, caesarean section; NICU, neonatal intensive care unit; SCN, special care nursery; TSV, term singletons in vertex 
presentation. 
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significant reduction in the odds of 5 min Apgar score <7 
among TSV born to mothers with diabetes during preg-
nancy who were born after prelabour CS at 38 weeks’ 
gestation compared with those born after planned 
vaginal birth at 39 weeks’ gestation.18
TSV born to mothers with diabetes during pregnancy 
can be affected by a number of morbidities including 
respiratory distress syndrome, hypoglycaemia and hypo-
calcaemia that can lead to an increase in the likelihood 
of admission to NICU/SCN.5 In addition, CS is associated 
with increased odds of neonatal respiratory morbidity.19 
The NICE guideline recommended admission to NICU if 
babies who were born to mothers with diabetes had one 
of the following symptoms: hypoglycaemia, respiratory 
distress or jaundice, signs of cardiac decompensation, 
neonatal encephalopathy or polycythaemia, the need for 
tube feeding or who were born preterm.5
Our study found that instrumental vaginal birth 
and intrapartum CS were associated with an increase 
in the odds of the need for resuscitation and admis-
sion to NICU/SCN compared with non-instrumental 
vaginal birth. One indication for instrumental vaginal 
birth and intrapartum CS is fetal compromise,20 which 
is also an indication for neonatal resuscitation.21 Thus, 
requiring resuscitation might have been associated with 
fetal compromise, not the use of instrumental vaginal 
birth or intrapartum CS. However, instrumental vaginal 
birth alone is also considered a risk factor for requiring 
neonatal resuscitation.21
Our study found that women with diabetes have a low 
rate of non-instrumental vaginal birth and high rate of 
giving birth by intrapartum CS and instrumental birth. 
This is consistent with previous studies.18 22 Among our 
population of mothers who went into labour, 38.8% of 
those with pre-existing diabetes and 31.5% of those with 
GDM gave birth by instrumental vaginal birth or intra-
partum CS compared with 29.4% of women in the NSW 
general population.23 One in four mothers (25.9%) with 
planned vaginal birth gave birth to a macrosomic TSV by 
intrapartum CS, and one in five mothers (20.5%) with 
planned vaginal birth gave birth to a non-macrosomic 
TSV by instrumental vaginal birth. Given that both intra-
partum CS and instrumental birth are associated with 
increased odds of adverse neonatal outcomes, the high 
proportion of resorting to instrumental vaginal birth for 
non-macrosomic TSV or intrapartum CS for macrosomic 
TSV should be considered when planning vaginal births.
Although prelabour CS was associated with a reduc-
tion in some adverse neonatal outcomes, specifically 
requiring resuscitation for macrosomic TSV, prelabour 
CS is associated with adverse maternal outcomes. In the 
general population, CS is associated with immediate 
risk to the mother of infection, haemorrhage, anaes-
thetic risks and mortality.24 It is also associated with 
an increased likelihood of repeat elective CS in future 
pregnancies and increased risk of stillbirth and placenta 
praevia and accreta, uterine rupture, and peripartum 
hysterectomy.24 The risk of adverse maternal outcomes 
following CS might be escalated for women with diabetes 
during pregnancy since they are at higher risk of adverse 
maternal outcomes (such as infection and impaired 
wound healing) than women without diabetes.25
COnClusIOn
Of mothers with planned vaginal birth, one in four gave 
birth to a macrosomic TSV by intrapartum CS and one in 
five gave birth to a non-macrosomic TSV by instrumental 
vaginal birth. The potential risk of adverse neonatal 
outcomes associated with intrapartum CS and instru-
mental vaginal birth should be considered when plan-
ning for birth of women with diabetes. Close monitoring 
and readiness to intervene are needed when planning 
labour for TSV, particularly when the baby is macrosomic 
as CS is often required to expedite birth.
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